The market for tuberculosis (TB) therapies is anticipated to expand at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2024 and 2032 as a result of increased TB occurrences, growing public awareness of the illness, and improvements in available treatments. Latent TB requires preventative care, but active TB is the more severe variety that requires ...
Read More »